FindTrial
Sign In

GOut TrEatment STrategy (GO TEST) FINALE study, a multicentre pragmatic randomized superiority trial of continuation versus cessation of urate lowering therapies in gout in remission.

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-511111-13-01
Enrollment
310
Registered
2024-07-09
Start date
2024-07-09
Completion date
2025-06-16
Last updated
2024-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gout

Brief summary

The between group difference in proportion of patients fulfilling the adapted preliminary gout remission criteria during the last 6 months of 24 month follow up using superiority testing. If superiority is not shown, non-inferiority testing with a prespecified NI margin of 0.08 will be performed exploratory as secondary outcome.

Interventions

DRUGALLOPURINOL
DRUGBENZBROMARONE
DRUGFEBUXOSTAT

Sponsors

Sint Maartenskliniek
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
The between group difference in proportion of patients fulfilling the adapted preliminary gout remission criteria during the last 6 months of 24 month follow up using superiority testing. If superiority is not shown, non-inferiority testing with a prespecified NI margin of 0.08 will be performed exploratory as secondary outcome.—

Countries

Netherlands

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026